Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-17-047588
Filing Date
2017-08-03
Accepted
2017-08-03 20:54:53
Documents
1
Period of Report
2017-08-01

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 13763
  Complete submission text file 0001209191-17-047588.txt   15393
Mailing Address 19820 NORTH CREEK PARKWAY SUITE 201 BOTHELL WA 98011
Business Address 19820 NORTH CREEK PARKWAY SUITE 201 BOTHELL WA 98011 425-686-1500
ACHIEVE LIFE SCIENCES, INC. (Issuer) CIK: 0000949858 (see all company filings)

EIN.: 954343413 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2835 In Vitro & In Vivo Diagnostic Substances

Mailing Address C/O TRIMERIS, INC. 2530 MERIDIAN PARKWAY, 2ND FLOOR DURHAM NC 27713
Business Address
MATTINGLY MARTIN A (Reporting) CIK: 0001265782 (see all company filings)

Type: 4 | Act: 34 | File No.: 033-80623 | Film No.: 171006683